Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2022 · 25 citations · 45 references
Life SciencesNeurologyNeuroscienceDementiaNeurodegenerationNeuropathologyAlzheimer DiseaseBiomarkers Of NeurodegenerationCerebrospinal Fluid BiomarkersDiffusion ImagingNeurodegenerative DiseasesNeurodegenerative DisordersBrain Microstructure ImagingCerebrospinal Fluid MarkersCerebrospinal Fluid Neurodegeneration MarkersCerebrospinal Fluid TauDiffusion Magnetic Resonance ImagingDiffusion Tensor Imaging MarkersStructural Magnetic Resonance Imaging MarkersWhite Matter Hyperintensity Markers
Introduction: White matter (WM) degeneration is a critical component of early Alzheimer's disease (AD) pathophysiology. Diffusion-weighted imaging (DWI) models, including diffusion tensor imaging (DTI), neurite orientation dispersion and density imaging (NODDI), and mean apparent propagator MRI (MAP-MRI), have the potential to identify early neurodegenerative WM changes associated with AD. Methods: We imaged 213 (198 cognitively unimpaired) aging adults with DWI and used tract-based spatial statistics to compare 15 DWI metrics of WM microstructure to 9 cerebrospinal fluid (CSF) markers of AD pathology and neurodegeneration treated as continuous variables. Results: and pTau, compared with NODDI and DTI. Discussion: Our results suggest that WM degeneration may be more pervasive in AD than is commonly appreciated and that innovative DWI models such as MAP-MRI may provide clinically viable biomarkers of AD-related neurodegeneration in the earliest stages of AD progression.
45
Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data
Stephen M. Smith, Mark Jenkinson, Heidi Johansen‐Berg et al. · NeuroImage · 2006 · 6.6K citations
Permutation inference for the general linear model
Anderson M. Winkler, Gerard R. Ridgway, Matthew Webster et al. · NeuroImage · 2014 · 3.8K citations · Full text